Recombinant monoclonal antibody to IL1 beta. Gevokizumab is a humanized monoclonal antibody used in the treatment of diabetes and inflammatory disorders.
Figure 1 Anti-Human IL1 beta Recombinant Antibody (Gevokizumab) (TAB-161) in SDS-PAGE
SDS-PAGE analysis of TAB-161 in reduced (Lane 1) and non-reduced (Lane 2) conditions. Gel stained for 30 minutes with Coomassie Blue. As a result, different β-mercaptoethanol-reduced proteins (Heavy chain and Light chain) migrate as about 50 kDa and 25 kDa, respectively.
The purity of TAB-161 was greater than 95% as determined by SDS-PAGE.
Figure 2 Anti-Human IL1 beta Recombinant Antibody (Gevokizumab) (TAB-161) in HPLC
The purity of TAB-161 was greater than 95% as determined by SEC-HPLC.
Figure 3 Anti-Human IL1 beta Recombinant Antibody (Gevokizumab) (TAB-161) in WB
Western blot analysis of TAB-161 was performed by loading Recombinant Human IL1 beta protein.
TAB-161 incubation concentration: 2 ng/μL.
The secondary antibody: HRP-goat anti-human IgG
Lane 1: Reducing Antigen (0.1 μg)
Lane 2: Reducing Antigen (0.3 μg)
Lane 3: Reducing Antigen (0.6 μg)
Figure 4 Anti-Human IL1 beta Recombinant Antibody (Gevokizumab) (TAB-161) in ELISA
ELISA analysis of TAB-161 was performed by coating with Recombinant Human IL1 beta Protein. Then blocked with BSA and incubated with Anti-Human IL1 beta Recombinant Antibody (Gevokizumab) (TAB-161). The Goat Anti-Human IgG-HRP as a secondary antibody. Detection was performed using TMB substrate and stopped with sulfuric acid. The absorbances were read on a spectrophotometer at 450 nm.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Afuco™ Anti-IL1B ADCC Recombinant Antibody (Gevokizumab), ADCC EnhancedThis product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to IL1 beta. Gevokizumab is a humanized monoclonal antibody used in the treatment of diabetes and inflammatory disorders.
CAT | Product Name | Application | Type |
---|---|---|---|
PSBL-239 | Human Anti-IL1B Recombinant Antibody (clone YC129); scFv Fragment | WB, IHC, FuncS | Human scFv |
HPAB-2338LY-S(P) | Human Anti-IL1B Recombinant Antibody; scFv Fragment (HPAB-2338LY-S(P)) | ELISA | Human scfv |
HPAB-N0148-YC-S(P) | Human Anti-IL1B Recombinant Antibody (clone 048Ab-4); scFv Fragment | ELISA | Human scFv |
HPAB-1228-FY-F(E) | Human Anti-IL1B Recombinant Antibody; Fab Fragment (HPAB-1228-FY-F(E)) | ELISA | Humanized Fab |
HPAB-1861-FY-F(E) | Human Anti-IL1B Recombinant Antibody (clone Hu007); scFv Fragment | Neut | Humanized scFv |
CAT | Product Name | Application | Type |
---|---|---|---|
PFBL-239 | Human Anti-IL1B Recombinant Antibody (clone YC129); Fab Fragment | WB, IHC, FuncS | Human Fab |
PFBL-603 | Human Anti-IL1B Recombinant Antibody (clone ACZ885); Fab Fragment | Neut | Human Fab |
HPAB-2338LY-F(E) | Human Anti-IL1B Recombinant Antibody; Fab Fragment (HPAB-2338LY-F(E)) | ELISA | Human Fab |
HPAB-0729-FY-S(P) | Mouse Anti-IL1B Recombinant Antibody; scFv Fragment (HPAB-0729-FY-S(P)) | ELISA, Neut | Mouse scFv |
HPAB-0730-FY-S(P) | Mouse Anti-IL1B Recombinant Antibody; scFv Fragment (HPAB-0730-FY-S(P)) | ELISA, Neut | Mouse scFv |
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-232CT | Anti-Human IL-1β (Interleukin 1 beta) Recombinant Antibody (ch47F11) | Inhibition | Chimeric antibody (mouse/human) |
TAB-237CT | Anti-Human IL-1β (Interleukin 1 beta) Recombinant Antibody (chSK48-E26) | ELISA, Neut | Chimeric antibody (mouse/human) |
TAB-232CT-F(E) | Anti-Human IL-1β (Interleukin 1 beta) Recombinant Antibody Fab Fragment (ch47F11) | Inhibition | Chimeric antibody (mouse/human) |
TAB-237CT-F(E) | Anti-Human IL-1β (Interleukin 1 beta) Recombinant Antibody Fab Fragment (chSK48-E26) | ELISA, Neut | Chimeric antibody (mouse/human) |
TAB-543LC-S(P) | Anti-human IL1B scFv Fragment, Chimeric | ELISA | Chimeric antibody (mouse/human) |
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-230CT-S(P) | Mouse Anti-IL1B Recombinant Antibody; scFv Fragment (TAB-230CT-S(P)) | ELISA | Mouse scFv |
TAB-231CT-S(P) | Anti-Human IL-1β (Interleukin 1 beta) Recombinant Antibody scFv Fragment (47F11) | Inhibition | |
TAB-234CT-S(P) | Rabbit Anti-IL1B Recombinant Antibody; scFv Fragment (TAB-234CT-S(P)) | FC, ELISA, Neut | Rabbit scFv |
TAB-235CT-S(P) | Anti-Human IL-1β (Interleukin 1 beta) Recombinant Antibody scFv Fragment (SK48-E26) | ELISA, Neut | |
TAB-548LC-F(E) | Rabbit Anti-IL1B Recombinant Antibody; Fab Fragment (TAB-548LC-F(E)) | ELISA, SPR | Rabbit Fab |
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-233CT-S(P) | Human Anti-IL1B Recombinant Antibody; scFv Fragment (TAB-233CT-S(P)) | ELISA | Humanized scFv |
TAB-236CT-S(P) | Anti-Human IL-1β (Interleukin 1 beta) Recombinant Antibody scFv Fragment (huSK48-E26) | ELISA, Neut | Humanized antibody |
TAB-544LC | Anti-human IL1B Recombinant Antibody, Humanized (TAB-544LC) | ELISA | Humanized antibody |
TAB-549LC | Human Anti-IL1B Recombinant Antibody (TAB-549LC) | ELISA, SPR, Inhib | Humanized antibody |
TAB-549LC-F(E) | Human Anti-IL1B Recombinant Antibody; Fab Fragment (TAB-549LC-F(E)) | ELISA, SPR | Humanized Fab |
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-550LC-S(P) | Anti-human IL1B scFv Fragment (9.5.2) | ELISA | Human antibody |
TAB-551LC-S(P) | Anti-human IL1B scFv Fragment (5.5.1) | ELISA | Human antibody |
TAB-552LC-S(P) | Anti-human IL1B scFv Fragment (8.18.1) | ELISA | Human antibody |
TAB-553LC-S(P) | Anti-human IL1B scFv Fragment (6.20.1) | ELISA | Human antibody |
TAB-554LC-S(P) | Anti-human IL1B scFv Fragment (6.33.1) | ELISA | Human antibody |
CAT | Product Name | Application | Type |
---|---|---|---|
BRD-0282MZ | Chicken Anti-Interleukin-1β Polyclonal IgY | WB, Indirect ELISA | Chicken antibody |
CAT | Product Name | Application | Type |
---|---|---|---|
NEUT-1271CQ | Recombinant Mouse Anti-IL1B Antibody (CBL665) | Neut | IgG1 |
NEUT-1272CQ | Mouse Anti-IL1B Recombinant Antibody (clone 4M27) | IHC, Neut, WB | Mouse IgG2 |
NEUT-1273CQ | Mouse Anti-IL1B Recombinant Antibody (clone 8516.311) | ELISA, WB, Neut | Mouse IgG1 |
NEUT-1275CQ | Mouse Anti-IL1B Recombinant Antibody (clone 2805R) | ELISA, Neut, WB, ICC | Mouse IgG1 |
NEUT-1276CQ | Mouse Anti-IL1B Recombinant Antibody (clone CBL697) | Neut, ELISA | Mouse IgG |
CAT | Product Name | Application | Type |
---|---|---|---|
NEUT-1274CQ | Mouse Anti-IL1B Recombinant Antibody (clone B-A15) | Block, FC | Mouse IgG1 |
NEUT-1285CQ | Mouse Anti-IL1B Recombinant Antibody (clone H1b-27) | ELISA, ELISPOT, Block | Mouse IgG2b, κ |
CAT | Product Name | Application | Type |
---|---|---|---|
MOR-1798 | Rabbit Anti-IL1B Recombinant Antibody (clone DS1798AB) | WB | Rabbit IgG |
MOR-4237 | Rabbit Anti-IL1B Recombinant Antibody (clone SI316DS) | ELISA | Rabbit IgG |
MOR-4238 | Rabbit Anti-IL1B Recombinant Antibody (clone SI317DS) | ELISA | Rabbit IgG |
MOR-4239 | Rabbit Anti-IL1B Recombinant Antibody (clone SI318DS) | ELISA | Rabbit IgG |
MOR-4605 | Rabbit Anti-IL1B Recombinant Antibody (clone TH118DS) | WB | Rabbit IgG |
CAT | Product Name | Application | Type |
---|---|---|---|
HPAB-0330-FY | Mouse Anti-IL1B Recombinant Antibody (clone 048-Ab-1) | In vivo, ELISA | Mouse IgG |
HPAB-0331-FY | Mouse Anti-IL1B Recombinant Antibody (clone 048-Ab-3) | In vivo, ELISA | Mouse IgG |
HPAB-0332-FY | Mouse Anti-IL1B Recombinant Antibody (clone 048-Ab-6) | In vivo, ELISA | Mouse IgG |
HPAB-0333-FY | Human Anti-IL1B Recombinant Antibody (clone pAb) | ELISA | Human IgG |
HPAB-1228-FY | Human Anti-IL1B Recombinant Antibody (HPAB-1228-FY) | Inhib, WB, Neut | Humanized IgG |
CAT | Product Name | Application | Type |
---|---|---|---|
AFC-TAB-021 | Afuco™ Anti-IL1B ADCC Recombinant Antibody (Canakinumab), ADCC Enhanced | ELISA, IP, FC, FuncS, Neut | ADCC enhanced antibody |
AFC-TAB-161 | Afuco™ Anti-IL1B ADCC Recombinant Antibody (Gevokizumab), ADCC Enhanced | ELISA, FC, IP, FuncS, IF, Neut | ADCC enhanced antibody |
There are currently no Customer reviews or questions for TAB-161. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.